![](https://sbx-attachments-production.s3.us-east-2.amazonaws.com/dslpivuhj68catn8rfzv7p1n8gca?response-content-disposition=inline%3B%20filename%3D%22hippos.png%22%3B%20filename%2A%3DUTF-8%27%27hippos.png&response-content-type=image%2Fpng&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA6MHW4YOXXGMMU2FH%2F20250114%2Fus-east-2%2Fs3%2Faws4_request&X-Amz-Date=20250114T131348Z&X-Amz-Expires=172800&X-Amz-SignedHeaders=host&X-Amz-Signature=624460de8e89c9ffe06a37429e8228ace64b94ee97fa058e0c1d2a8c558f6f9b)
Vaccines against COVID-19 were developed in record-smashing time, and now that the rollout has begun, attention is returning to herd immunity, in a real rather than hypothetical sense.
Herd immunity refers to the protection against an infectious disease that arises when a critical mass of individuals in a population becomes immune. The pathogen can't find welcoming bodies, and the epidemic dies out. Once herd immunity is attained, mitigation measures can be relaxed. But if society opens too soon, a second and even third wave of disease can ensue – as we've seen.
A vaccine, engineered to evoke a strong and diverse antibody response, is more likely to build herd immunity than is natural infection.
Establishing herd immunity against COVID-19 requires that a whole bunch of ducks align. The variables include:
To continue reading, go to my DNA Science blog, where this post first appeared.